MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study. Lv M. Breast J 2023;2023:9508632.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lv M. MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study. Breast J 2023;2023:9508632.
PMID: 36846347